Credit Suisse Maintains Their Hold Rating on Bristol Myers (BMY)
In a report released today, Vamil Divan from Credit Suisse maintained a Hold rating on Bristol Myers (BMY – Research Report), with a price target of $59. The company’s shares opened today More »
New Buy Rating for Microsoft (MSFT), the Technology Giant
In a report released today, Brad Zelnick from Credit Suisse maintained a Buy rating on Microsoft (MSFT – Research Report), with a price target of $125. The company’s shares opened today at More »
